EUVIMEDEUVIMED entdecken
Crossref

Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A2

Haruka Hakoi, Yoshimi Miki, Saki Nomura, Kimiko Nakajima, Chiaki Terashima-Murase, Takuya Takeichi, Shigetoshi Sano, Masashi Akiyama, Shin-Ichi Sakasegawa, Makoto Murakami, Kei Yamamoto

Biochimie · 2023

DOI: 10.1016/j.biochi.2023.09.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimie, 2023. Verfasst von Haruka Hakoi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan. Electr…. Hauptthemen laut MEDLINE: Psoriasis, Phospholipases A2, Secretory. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidermal lipids play important roles in skin homeostasis and diseases. Psoriasis is an inflammatory disease characterized by keratinocyte hyperproliferation and Th17 immune responses. We previously reported that ethanolamine-type lysoplasmalogen (P-LPE), preferentially produced by group IIF secreted PLA2 (sPLA2-IIF/PLA2G2F) that is expressed in the suprabasal epidermis, promotes epidermal hyperplasia in psoriatic inflammation. Herein, we show that forcible degradation of epidermal P-LPE by topical application of recombinant lysophospholipase D (LyPls-PLD) from Thermocrispum, a lysoplasmalogen-specific hydrolase, attenuated epidermal hyperplasia and inflammation in imiquimod-induced and K5.Stat3C-transgenic mouse psoriasis models. In humans, P-LPE levels were elevated in the tape-stripped stratum corneum of patients with psoriasis. Moreover, in primary cultured human epidermal keratinocytes, aberrant cell proliferation and activation by psoriatic cytokines were sPLA2-IIF/P-LPE-dependent and were suppressed by the addition of LyPls-PLD with a decrease in P-LPE. These findings confirm that the sPLA2-IIF/P-LPE axis in the epidermis indeed regulates psoriasis, that P-LPE is a lipid biomarker that predicts the severity of psoriasis, and that pharmacological removal of this bioactive lipid is useful to prevent the disease. Thus, our study may lead to the development of drug discovery and diagnostic techniques based on this pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisPhospholipases A2, SecretoryMiceAnimalsHumansHyperplasiaEpidermisKeratinocytesInflammationMice, TransgenicLipidsLysophospholipase DLysophospholipids

Stichwörter der Autor:innen

Group IIF phospholipase A(2)LipidomicsLysoplasmalogenPsoriasisThermocrispum lysophospholipase D

Substanzen

Phospholipases A2, SecretoryLipidsLysophospholipase DlysoplasmalogensLysophospholipids

Autor:innen und Institutionen

  • Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan. Electronic address: hakoi501504001@gmail.com.
  • Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan; Laboratory of Microenvironmental Metabolic Health Sciences, Center for Disea…
  • Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan. Electronic address: c702232009@tokushima-u.ac.jp.
  • Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan. Electronic address: nakajimk@kochi-u.ac.jp.
  • Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: chiaki-m@med.nagoya-u.ac.jp.
  • Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: takeichi@med.nagoya-u.ac.jp.

Zitieren

APA

Hakoi, H., Miki, Y., Nomura, S., Nakajima, K., Terashima-Murase, C., Takeichi, T., Sano, S., Akiyama, M., Sakasegawa, S. I., Murakami, M., & Yamamoto, K. (2023). Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A2. Biochimie. https://doi.org/10.1016/j.biochi.2023.09.027

Vancouver

Hakoi H, Miki Y, Nomura S, Nakajima K, Terashima-Murase C, Takeichi T, et al. Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A2. Biochimie. 2023. doi:10.1016/j.biochi.2023.09.027

BibTeX
@article{Hakoi2023,
  author = {Hakoi, Haruka and Miki, Yoshimi and Nomura, Saki and Nakajima, Kimiko and Terashima-Murase, Chiaki and Takeichi, Takuya and Sano, Shigetoshi and Akiyama, Masashi and Sakasegawa, Shin-Ichi and Murakami, Makoto and Yamamoto, Kei},
  title = {Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A2},
  journal = {Biochimie},
  year = {2023},
  doi = {10.1016/j.biochi.2023.09.027}
}
Kostenlos starten →